21:55:01 EST Fri 22 Feb 2019
Enter Symbol
or Name

Benchmark Botanics Inc
Symbol C : BBT
Shares Issued 134,186,852
Close 2018-07-12 C$ 0.57
Recent Sedar Documents

Benchmark Botanics receives licence to import

2018-07-12 16:05 ET - News Release

Mr. Zhang Johnson reports


Benchmark Botanics Inc. has been issued a licence to import by Health Canada.

This import licence allows Benchmark, through its 100-per-cent-owned subsidiary, Potanicals Green Growers, access to a wide variety of genetics and strains for production. With this permit in hand, Benchmark executed a purchase order on July 11, 2018, with Dutch Passion from the Netherlands to import over 200 seeds, representing 70 different strains.

The medical profile of these strains ranges from very high-cannabidiol (CBD)/low-THC (tetrahydrocannabinol) to high-THC/low-CBD, one to one, THC to CBD strains. This is expected to provide the company with a number of production options to fulfill expected current and future market demand following receipt of a licence to sell.

"With the recent announcements regarding legalization of marijuana in Canada, this licence to import will allow us to further develop our product catalogue. It is a great step forward," stated Zhang Johnson, chief executive officer of Benchmark.

About Benchmark Botanics Inc.

Benchmark is a publicly traded company based in Vancouver, B.C., that is positioned to provide financing, partnership and acquisition opportunities to licensed producers and ancillary businesses within the global cannabis industry.

In November, 2017, the company acquired its first subsidiary, Potanicals Green Growers Inc. Potanicals Green Growers possesses a Health Canada licence to cultivate cannabis and is an Access to Cannabis for Medical Purposes (ACMPR) licensed producer. In its first phase of operations, Potanicals is currently cultivating in its 12,700-square-foot phase 1 indoor production facility. Benchmark is pursuing additional sites to retrofit for large-scale cultivation expansion.

We seek Safe Harbor.

© 2019 Canjex Publishing Ltd. All rights reserved.